Claims Data May Be Best For Formulary-Directed Pharmacoeconomic Models
Executive Summary
Drug companies should use pharmacoeconomic models based on claims data to position their products on formularies, University of Texas Center for Pharmacoeconomics Associate Director Jim Smeeder said.